Country Profile | UHC Live Monitoring

America Region

Bahamas

UHC Partnership Implementation

Status

Activities

Status

Start date

Date

GPW

GPW Outcomes

GPW Outputs

Ongoing

Strengthen PHC capacity for prevention and management of NCDs through increased population awareness and improved clinical management, including enhancing health education efforts for NCDs (2026-2028)

Jan 01, 2026 Dec 31, 2027

Last updated: May 27, 2026 by admin

Review / update Activity

Ongoing

Product/Service

Standards for comprehensive NCD care within health systems

Jan 01, 2026 Dec 31, 2027

GPW

GPW 14

GPW Output

4.1.1 WHO develops evidence-based policies and supports the implementation, scale-up and measurement of best buys and other actions to strengthen person-centered prevention, control and management of noncommunicable diseases

GPW Output Indicator

Country has evidence-based national guidelines/protocols/standards aligned with WHO guidance for the management of major NCDs through a primary care approach

GPW Outcome

4.1 Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance

GPW Outcome Indicator

Prevalence of controlled hypertension, among adults aged 30–79 years

Phase 5 Output

3.2 - Equity in access to quality services improved

Phase 5 Objective

SO3 - Accelerated progress towards universal access to basic health services, to achieve UHC.

Ongoing

Strengthen MCH services, with emphasis on the Elimination of Mother-to-Child Transmission (EMTCT) of HIV to provide continuous quality care to pregnant women and children: 1) Capacity building for health personnel (public and private). (2026) 2) Capacity building to strengthen integrated prevention, case management, and referral pathways for syphilis and HBV for seropositive pregnant women, their partners, and exposed infants. (2027) 3) EMTCT validation of syphilis and HBV. (2028)

Jan 01, 2026 Dec 31, 2028

Last updated: May 27, 2026 by admin

Review / update Activity

Ongoing

Product/Service

Guidance to support maternal, newborn, child and adolescent health programmes

Jan 01, 2026 Dec 31, 2028

GPW

GPW 14

GPW Output

4.2.1 WHO provides guidance and technical assistance to improve sexual, reproductive, maternal, newborn, child, adolescent, adult and older person health

GPW Output Indicator

Country has a strategic plan (whose development was supported by WHO) whose end date has not expired for two or more areas of Sexual, Reproductive, Maternal, Newborn, Child, and Adolescent Health (SRMNCAH)

GPW Outcome

4.2 Equity in access to sexual, reproductive, maternal, newborn, child, adolescent, and older person health and nutrition services and immunization coverage improved

GPW Outcome Indicator

SDG 5.6.1 Proportion of women aged 15–49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care

Phase 5 Output

3.3 - Equity in access to sexual, reproductive, maternal, newborn, child, adolescent health

Phase 5 Objective

SO3 - Accelerated progress towards universal access to basic health services, to achieve UHC.

Ongoing

Strengthening national (Infection Prevention and Control ) IPC program: 1) Support IPC and Antimicrobial Resistance (AMR) awareness raising in the health sector, community and among stakeholders and partners in an effort to prevent and control infections and AMR in The Bahamas, especially in the context of public health emergencies and climate-related crisis. (2026) 2) Support IPC and Antimicrobial Resistance (AMR) awareness raising in the health sector, community and among stakeholders and partners in an effort to prevent and control infections and AMR in The Bahamas. (2027) 3) Support IPC and Antimicrobial Resistance (AMR) awareness raising in the health sector, community and among stakeholders and partners in an effort to prevent and control infections and AMR in The Bahamas. (2028)

Jan 01, 2026 Dec 31, 2027

Last updated: May 27, 2026 by admin

Review / update Activity

Ongoing

Product/Service

Guidance and tools to optimize antimicrobial use and treatment, AWaRe and SECURE

Jan 01, 2026 Dec 31, 2027

GPW

GPW 14

GPW Output

4.1.4 WHO develops and disseminates guidance and tools to mitigate antimicrobial resistance, collects and reports data for action, raises awareness, guides research and innovation, builds country and regional capacity to implement a core package of i

GPW Output Indicator

Implementing and monitoring government-endorsed multisectoral antimicrobial resistance national action plan based on WHO guidance with necessary financing

GPW Outcome

4.1 Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance

GPW Outcome Indicator

SDG 3.d.2 Percentage of bloodstream infections due to selected antimicrobial-resistant organisms

Phase 5 Output

3.1 - The primary health care approach is strengthened

Phase 5 Objective

SO3 - Accelerated progress towards universal access to basic health services, to achieve UHC.

Download CSV

GPW 13
-1.1 Improved access to quality essential health services irrespective of gender, age or disability status
-1.2 Reduced number of people suffering financial hardship
-1.3 Improved access to essential medicines, vaccines, diagnostics and devices for primary health care
-2.1 Countries prepared for health emergencies
-2.2 Epidemics and pandemics prevented
-2.3 Health emergencies rapidly detected and responded to
-3.1 Safe and equitable societies through addressing health determinants
-3.2 Supportive and empowering societies through addressing health risk factors
-3.3 Healthy environments to promote health and sustainable societies
-4.1 Strengthened country capacity in data and innovation
-4.2 Strengthened leadership, governance and advocacy for health
-4.3 Financial, human, and administrative resources managed in an efficient, effective, results-oriented and transparent
GPW 14
-1.1 More climate-resilient health systems are addressing health risks and impacts
-1.2 Lower-carbon health systems and societies are contributing to health and well-being
-2.1 Health inequities reduced by acting on social, economic, environmental and other determinants of health
-2.2 Priority risk factors for noncommunicable and communicable diseases, violence and injury, and poor nutrition reduced through multisectoral approaches
-2.3 Populations empowered to control their health through health promotion programmes and community involvement in decision-making
-3.1 The primary health care approach renewed and strengthened to accelerate universal health coverage
-3.2 Health and care workforce, health financing and access to quality-assured health products substantially improved
-3.3 Health information systems strengthened, and digital transformation implemented
-4.1 Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance
-4.2 Equity in access to sexual, reproductive, maternal, newborn, child, adolescent, and older person health and nutrition services and immunization coverage improved
-4.3 Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable
-5.1 Risks of health emergencies from all hazards reduced and impact mitigated
-5.2 Preparedness, readiness and resilience for health emergencies enhanced
-6.1 Detection of and response to acute public health threats is rapid and effective
-6.2 Access to essential health services during emergencies is sustained and equitable
-7.1 Effective WHO health leadership, through convening, agenda-setting, partnerships and communications, advances the sustainably financed GPW 14 outcomes and the goal of leaving no one behind
-7.2 Timely delivery, expanded access and uptake of high-quality WHO normative, technical and data products enable health impact at country level
-8.1 An efficiently managed WHO with strong oversight and accountability and strengthened country capacities better enables its workforce, partners and Member States to deliver the GPW 14 outcomes

GPW 13
-1.1.1 Countries enabled to provide high-quality, people-centred health services, based on primary health care strategies and comprehensive essential service packages
-1.1.2 Countries enabled to strengthen their health systems to deliver on condition- and disease-specific service coverage results
-1.1.3 Countries enabled to strengthen their health systems to address population-specific health needs and barriers to equity across the life course
-1.1.4 Countries’ health governance capacity strengthened for improved transparency, accountability, responsiveness and empowerment of communities
-1.1.5 Countries enabled to strengthen their health and care workforce
-1.2.1 Countries enabled to develop and implement equitable health financing strategies and reforms to sustain progress towards universal health coverage
-1.2.2 Countries enabled to produce and analyse information on financial risk protection, equity and health expenditures, and to use this information to track progress and inform decision-making
-1.2.3 Countries enabled to improve institutional capacity for transparent decision-making in priority-setting and resource allocation, and analysis of the impact of health in the national economy
-1.3.1 Provision of authoritative guidance and standards on quality, safety and efficacy of health products, essential medicines and diagnostics lists
-1.3.2 Improved and more equitable access to health products through global market shaping and supporting countries to monitor and ensure efficient and transparent procurement and supply systems
-1.3.3 Country and regional regulatory capacity strengthened, and supply of quality-assured and safe health products improved, including through prequalification services
-1.3.4 Research and development agenda defined and research coordinated in line with public health priorities
-1.3.5 Countries enabled to address antimicrobial resistance through strengthened surveillance systems, laboratory capacity, infection prevention and control, awareness-raising and evidence-based policies and practices
-2.1.1 All-hazards emergency preparedness capacities in countries assessed and reported
-2.1.2 Capacities for emergency preparedness strengthened in all countries
-2.1.3 Countries operationally ready to assess and manage identified risks and vulnerabilities
-2.2.3 Mitigate the risk of the emergence and re-emergence of high-threat pathogens and improve pandemic preparedness
-2.3.1 Potential health emergencies rapidly detected, and risks assessed and communicated
-2.3.2 Acute health emergencies rapidly responded to, leveraging relevant national and international capacities
-2.3.3 Essential health services and systems maintained and strengthened in fragile, conflict and vulnerable settings
-3.1.1 Countries enabled to address social determinants of health across the life course
-3.2.1 Countries enabled address risk factors through multisectoral action
-3.2.2 Countries enabled to reinforce partnerships across sectors, as well as governance mechanisms, laws and fiscal measures
-3.3.1 Countries enabled to address environmental determinants, including climate change
-4.1.1 Countries enabled to strengthen data, analytics and health information systems to inform policy and deliver impacts
-4.1.2 GPW 13 impacts and outcomes, global and regional health trends, Sustainable Development Goals indicators, health inequalities and disaggregated data monitored
-4.1.3 Strengthened evidence base, prioritization and uptake of WHO generated norms and standards and improved research capacity and the ability to effectively and sustainably scale up innovations, including digital technology, in countries.
-4.2.1 Leadership, governance and external relations enhanced to implement GPW 13 and drive impact in an aligned manner at the country level, on the basis of strategic communications and in accordance with the SDG in the context of United Nations reform
-4.2.2 The Secretariat operates in an accountable, transparent, compliant and risk management-driven manner including through organizational learning and a culture of evaluation
-4.2.3 Strategic priorities resourced in a predictable, adequate and flexible manner through strengthening partnerships
-4.2.4 Planning, allocation of resources, monitoring and reporting based on country priorities, carried out to achieve country impact, value-for-money and the strategic priorities of GPW 13
-4.2.6 “Leave no one behind” approach focused on equity, gender and human rights progressively incorporated and monitored
-4.3.1 Sound financial practices and oversight managed through an efficient and effective internal control framework
-4.3.3 Effective, innovative and secure digital platforms and services aligned with the needs of users, corporate functions, technical programmes and health emergencies operations
-4.3.4 Safe and secure environment, with efficient infrastructure maintenance, cost-effective support services and responsive supply chain, including occupational health and safety
GPW 14
-1.1.1 WHO supports countries in developing health vulnerability and adaptation assessments, and national adaptation plans, and provides guidance, capacity-building and piloting of interventions to enhance the climate resilience of health systems thro
-1.2.1 WHO develops norms, standards, policy guidance and strengthens capacity in countries to reduce greenhouse gases and other pollutants from the health sector, and engage other sectors (such as food, transport, energy, education) to reduce their e
-2.1.1 WHO supports countries in designing policies and regulations, shaping resource allocation and investment, building capacity and in establishing partnerships within and beyond the health sector to address social determinants and reduce health in
-2.1.2 WHO supports countries in developing evidence-informed policies across sectors at all levels of government and adapts public health measures to meet the health needs of populations such as migrants and displaced people
-2.2.1 WHO develops norms, standards and technical packages to address risk factors for communicable and noncommunicable diseases, violence and injuries, prevent poor nutrition and strenghten food safety and reduce environmental health risks, and supp
-2.2.2 WHO supports countries to ensure comprehensive access to promotion and preventive health services to populations (such as tobacco and alcohol cessation services, physical activity counselling and nutrition counselling, including for breastfeedi
-2.3.1 WHO develops guidance and supports countries to strengthen their capacity to engage with and empower individuals and communities, and all levels of government across sectors to increase health literacy, enable healthier behaviours, advance co-b
-3.1.1 WHO strengthens country capacity and provides guidance on the design, delivery, quality and measurement of integrated -services
-3.1.2 WHO strengthens the capacity of national public health institutions to deliver essential public health functions and improve the resilience of health systems
-3.1.3 WHO strengthens countries’ national capacity to develop implementable national strategies for UHC
-3.2.1 WHO provides technical guidance and operational support to countries to optimize and expand their health and care workforce
-3.2.2 WHO generates evidence, guides design and supports health-related macroeconomic policies and practices for sustainable health financing
-3.2.3 WHO supports countries to implement measures for better access to, and use of, safe, effective and quality-assured health products
-3.3.1 WHO builds country capacity and develops tools and platforms to support countries in developing and improving their national digital health and health information systems to improve resilience, coverage, equity and impact
-4.1.1 WHO develops evidence-based policies and supports the implementation, scale-up and measurement of best buys and other actions to strengthen person-centered prevention, control and management of noncommunicable diseases
-4.1.2 WHO supports the design, scale-up, implementation and measurement of the coverage of people-centred, equitable services for key mental health, neurological and substance use conditions
-4.1.3 WHO provides leadership, develops evidence-based guidance and standards, and supports Member States to build capacity for delivery of targeted, innovative and integrated people-centred services for communicable diseases
-4.1.4 WHO develops and disseminates guidance and tools to mitigate antimicrobial resistance, collects and reports data for action, raises awareness, guides research and innovation, builds country and regional capacity to implement a core package of i
-4.2.1 WHO provides guidance and technical assistance to improve sexual, reproductive, maternal, newborn, child, adolescent, adult and older person health
-4.2.2 WHO provides guidance and technical assistance to strengthen and sustain quality immunization services, including for poliomyelitis, especially for unvaccinated and under-vaccinated persons
-4.3.1 WHO provides guidance and technical assistance and strengthens capacity to track health expenditures at the system level to monitor financial hardship and financial barriers to access and inform decision-making for financial and social health p
-5.1.1 WHO collaborates with partners to communicate risks and engage with communities to co-create public health prevention and response interventions for all hazards
-5.1.2 WHO provides technical expertise and operational support to strengthen and scale preventive population and environmental public health interventions for all hazards, utilizing a One Health approach
-5.2.1 WHO conducts risk and capacity assessments and supports the development and implementation of national preparedness and readiness plans, including tailored prevention and mitigation strategies for specific hazards
-5.2.2 WHO establishes and manages collaborative research networks for fast-track research and development, scalable manufacturing and resilient supply chain systems to enable timely and equitable access to medical countermeasures during health emerge
-5.2.3 WHO provides technical expertise and operational support to strengthen and scale clinical care for emergencies, including infection prevention and control measures to protect health workers and patients
-6.1.1 WHO strengthens surveillance and alert systems, including diagnostics and laboratory capacities, for the effective monitoring of public health threats and the rapid detection, verification, risk assessment and grading of public health events
-6.1.2 WHO coordinates rapid and effective responses to acute public health threats, including deploying multisectoral response capacities, surging emergency supplies and logistics support, providing contingency financing, and implementing strategic a
-6.2.1 WHO coordinates and leads the health cluster or sector and partners to assess health needs and develop, fund and monitor humanitarian health emergency response plans in humanitarian emergencies
-6.2.2 WHO ensures the provision of life-saving care and maintains essential health services and systems in emergencies and vulnerable settings, addressing barriers to access and inequity
-7.1.1 Convening, advocating and engagement with Member States and key constituencies in support of health governance and to advance health priorities
-7.1.2 Effectively communicating to promote evidence-informed planning for decision-making for interventions and healthy behaviours in countries
-7.1.3 Effective results-based management realized through a sustainably financed programme budget aligned with evidence-informed country, regional and global priorities, supported by transparent resource allocation and robust monitoring and performan
-7.2.1 Evidence-based and quality-assured normative products, including the living approach, are developed with and for countries, are digitally accessible and used for health, policy and practice impact
-7.2.2 Strengthening national and regional science ecosystems to improve health and provide opportunities and equity, active support for the digital health transformation, research, development and innovation, including manufacturing capacities of cou
-7.2.3 WHO supports Member States in strengthening health information collection, aggregation, analysis and interpretation to monitor trends and progress towards indicators and targets of the Sustainable Development Goals, including inequality monitor
-8.1.1 Policies, rules and regulations in place to attract, recruit and retain a diverse, empowered and fit-for-purpose workforce, operating in a respectful and inclusive workplace with organizational change fully institutionalized
-8.1.2 Core capacities of WHO country and regional offices strengthened to drive measurable impact at country level
-8.1.3 Accountability and legal functions enhanced in a transparent, compliant and risk management-driven manner, promoting organizational learning, effective internal justice, safety and impact at country level
-8.1.4 Fit-for-purpose, cost-effective, innovative and secure corporate digital platforms and services aligned with the needs of users, corporate functions and technical programmes
-8.1.5 Working environments, infrastructure, support services, supply chains and asset management are fit for purpose, accountable, cost-effective, innovative and secure for optimized operations
-8.1.6 Sound financial practices supported by an effective internal control framework to ensure transparency, accountability, and optimal financial management

Print / View PDF

UHC Partnership Implementation

Activities